METHODS FOR REDUCING FIBRINOGEN

摘要

1. The use of a compound having the formula wherein R is N-pyrrolidinyl or N-piperidinyl; or a pharmaceutically acceptable salt or solvate thereof. 2. The use according to claim 1 wherein R is N-piperidinyl. 3. The use according to Claim 2 wherein said compound is the hydrochloride salt thereof. 4. The use according to Claim 1 wherein said human is a female. 5. The use according to Claim 3 wherein said female is post-menopausal. 6. The use according to Claim 1 wherein the dose administered is 60 mg/day via the oral route.